The estimated Net Worth of James Nathan Clarke is at least $6.28 Million dollars as of 29 May 2020. Mr. Clarke owns over 747 units of PetIQ Inc stock worth over $54,907 and over the last 7 years he sold PETQ stock worth over $6,166,900. In addition, he makes $58,450 as Independent Director at PetIQ Inc.
James has made over 4 trades of the PetIQ Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 747 units of PETQ stock worth $22,918 on 29 May 2020.
The largest trade he's ever made was selling 166,000 units of PetIQ Inc stock on 28 September 2018 worth over $6,166,900. On average, James trades about 28,403 units every 87 days since 2018. As of 29 May 2020 he still owns at least 1,792 units of PetIQ Inc stock.
You can see the complete history of Mr. Clarke stock trades at the bottom of the page.
James N. Clarke serves as Independent Director of the Company. Mr. Clarke has served as a director since our IPO. Prior to our IPO, Mr. Clarke served as a member of PetIQ Holdings, LLC’s board of managers from 2012 until July 2017, serving as the board of managers’ chairman from 2012 until 2015. From 2011 until the formation of PetIQ Holdings, LLC in 2012, Mr. Clarke served as the chairman of PetIQ, LLC. Mr. Clarke is Chief Executive Officer and Managing Partner of Clarke Capital Partners, a growth equity and alternatives-focused family office, where he has served since 2011. Mr. Clarke is a director of several privately owned companies and non-profit organizations. Mr. Clarke is a Governor-appointed Trustee and Foundation Chair at Utah Valley University and also serves as the Chairman of the board of managers of Curza Global, LLC, a small-molecule drug development company focused on infectious diseases and oncology. Mr. Clarke is an alumnus of Brigham Young University and holds a Master of Management from the University of Oxford.
As the Independent Director of PetIQ Inc, the total compensation of James Clarke at PetIQ Inc is $58,450. There are 8 executives at PetIQ Inc getting paid more, with Susan Sholtis having the highest compensation of $2,434,320.
James Clarke is 47, he's been the Independent Director of PetIQ Inc since 2017. There are 12 older and 2 younger executives at PetIQ Inc. The oldest executive at PetIQ Inc is Ronald Kennedy, 73, who is the Independent Director.
James's mailing address filed with the SEC is 500 E Shore Dr #120, Eagle, ID 83616, USA.
Over the last 7 years, insiders at PetIQ Inc have traded over $329,773,374 worth of PetIQ Inc stock and bought 191,694 units worth $3,985,118 . The most active insiders traders include Mark L First, Helios Partners Iv, L.P.Eos... und Will Santana. On average, PetIQ Inc executives and independent directors trade stock every 13 days with the average trade being worth of $1,635,992. The most recent stock trade was executed by William J. Carter on 28 August 2024, trading 5,000 units of PETQ stock currently worth $153,200.
petiq is founded with a love of pets and a desire to improve pet lives with veterinarian recommended pet products, made here in the usa. petiq offers pet prescription medications, over-the-counter flea & tick preventatives, health & wellness supplements, and dog & cat treats - at savings to other brand name alternatives. the company's portfolio of brands includes minties® dental treats, advecta® and petaction® flea and tick preventatives, vetiq® health & wellness, delightibles® cat treats, and betsy farms® dog treats. products are distributed nationally through traditional retail partners. petiq is headquartered in eagle, idaho with manufacturing and distribution facilities in springville, utah; plano, texas; and daytona beach, florida. to learn more, visit petiq.com.
PetIQ Inc executives and other stock owners filed with the SEC include: